Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine or Riluzole for Corticosteroid-induced Memory and Mood Changes
NCT00283309Phase 4Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Memory impairment and corticosteroid-induced mood disorder comparing Memantine, Riluzole and Placebo (3 arms). Primary endpoints: Rey Auditory Verbal Learning Test at Day 7 and Internal State Scale Activation Subscale at Day 7. Started Nov 2005; status: terminated.
02
Drugs
memantineriluzole
03
Conditions
Memory impairmentcorticosteroid-induced mood disorder
Beyond the preview
Go deeper on NCT00283309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00283309.